Aberdeen Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.5M | Buy |
922,929
+320,508
| +53% | +$10.6M | 0.05% | 308 |
|
|
2025
Q1 | $24.2M | Buy |
602,421
+151,908
| +34% | +$6.11M | 0.05% | 345 |
|
|
2024
Q4 | $21.2M | Buy |
450,513
+102,457
| +29% | +$4.82M | 0.04% | 359 |
|
|
2024
Q3 | $18.4M | Sell |
348,056
-21,181
| -6% | -$1.12M | 0.03% | 404 |
|
|
2024
Q2 | $20M | Buy |
369,237
+129,995
| +54% | +$7.04M | 0.04% | 383 |
|
|
2024
Q1 | $16.8M | Buy |
239,242
+108,982
| +84% | +$7.64M | 0.03% | 442 |
|
|
2023
Q4 | $10.9M | Buy |
+130,260
| New | +$10.9M | 0.02% | 534 |
|